Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
Sekine
Yoshimoto
Y
Ouchi
Yasuomi
Y
Takei
Nori
N
Yoshikawa
Etsuji
E
Okada
Hiroyuki
H
Minabe
Yoshio
Y
Nakamura
Kazuhiko
K
Suzuki
Katsuaki
K
Iwata
Yasuhide
Y
Tsuchiya
Kenji J
KJ
Sugihara
Genichi
G
Mori
Norio
N
D000328:Adult; D014150:Antipsychotic Agents / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D006801:Humans; D007211:Indoles / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D054833:Isoindoles; D008297:Male; D049268:Positron-Emission Tomography; D020891:Raclopride / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D044348:Receptors, Serotonin, 5-HT2 / Q000378:metabolism*; D012016:Reference Values; D013134:Spiperone / Q000031:analogs & derivatives / Q000378:metabolism; D013844:Thiazoles / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics
D014150:Antipsychotic Agents; D007211:Indoles; D054833:Isoindoles; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; D044348:Receptors, Serotonin, 5-HT2; D013844:Thiazoles; D020891:Raclopride; D013134:Spiperone; C039167:3-N-methylspiperone; C065533:perospirone